Skip to search formSkip to main contentSkip to account menu

R-FM Regimen

Known as: Rituximab-Fludarabine-Mitoxantrone Regimen 
A regimen consisting of rituximab, fludarabine and mitoxantrone used for the treatment of indolent non-Hodgkin's lymphoma.
National Institutes of Health

Related topics

Related topics

4 relations
Mitoxantrone Hydrochloridefludarabineindolent lymphomarituximab

Search for papers about R-FM Regimen

Search papers
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)